SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-19T15:45:47.773233+00:00","dedupe_key":"signal_enriched:discovery_unusual_volume_delta:de0aec653ec56469","evidence_event_ids":["evt_c340fcdce471"],"signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/liquidias-lqda-ceo-sells-53000-shares-21-million","as_of":"2026-04-19T15:45:47.773233+00:00","canonical_url":"https://www.fool.com/coverage/filings/2026/04/19/liquidia-s-lqda-ceo-sells-53-000-shares-for-usd2-1-million/","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/liquidias-lqda-ceo-sells-53000-shares-21-million","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_876cbaa5d1cc3e33","canonical_host":"fool.com","canonical_is_aggregator":false,"canonical_url":"https://www.fool.com/coverage/filings/2026/04/19/liquidia-s-lqda-ceo-sells-53-000-shares-for-usd2-1-million/","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-19T16:15:32.042209+00:00","extraction_method":"trafilatura","fetched_description":"Key Points53,300 shares were sold indirectly for a transaction value of ~$2.14 million across April 14, 2026, to April 16, 2026, at a weighted average price of around $40.21 per share.","fetched_title":"Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million | Nasdaq","final_url":"https://www.nasdaq.com/articles/liquidias-lqda-ceo-sells-53000-shares-21-million","html_truncated":false,"paywall_likely":false,"publisher_domain":"fool.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/liquidias-lqda-ceo-sells-53000-shares-21-million","source_event_id":"evt_c340fcdce471","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"b68e0d0932f20f06","kind":"unusual_volume","published_at":"2026-04-19T15:03:06+00:00","publisher_domain":"fool.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["April 14, 2026","April 16, 2026","April 17, 2026","May 23, 2025","December 17, 2004","April 15, 2005","fourth quarter of 2025"],"entities":[{"asset_class":"equity","name":"Liquidia","relevance":"high","symbol":"LQDA","type":"company"},{"asset_class":"person","name":"Roger Jeffs","relevance":"high","symbol":"","type":"person"},{"asset_class":"private_entity","name":"Serendipity BioPharma LLC","relevance":"high","symbol":"","type":"entity"},{"asset_class":"regulatory_filing","name":"SEC Form 4","relevance":"medium","symbol":"","type":"filing"}],"event_type":"other","information_gaps":["The signal type requested 'unusual volume delta' including volume ratio vs average, but the provided text contains no volume metrics or baseline volume/ratio data.","The article does not provide confirmation from independent news sources beyond referencing the SEC Form 4 filing; it does not quantify market-wide volume changes.","No explicit catalyst is tied to the sale beyond the stated Rule 10b5-1 pre-scheduling; any 'most likely catalyst hypothesis' for unusual volume cannot be grounded in the provided text."],"key_facts":["53,300 shares of Liquidia common stock were sold indirectly.","The sale occurred across April 14, 2026 to April 16, 2026.","Total transaction value was approximately $2.14 million.","The weighted average price was around $40.21 per share (based on SEC Form 4).","Post-transaction value was based on the April 16, 2026 market close of about $41.40 per share.","The sale was executed entirely via Serendipity BioPharma LLC (no direct shares involved).","No derivative (option) activity was reported in the filing.","Direct and indirect holdings after the transaction were stated as 1,137,599 and 1,441,934 shares, respectively.","The article states the sale was executed under a Rule 10b5-1 plan (pre-scheduled).","The article states the 53,300 shares represent 2.02% of total holdings and 3.56% of the indirect position.","The article compares the 53,300-share sale size to a mean size of prior sell-only events (mean: 20,782 shares)."],"numeric_claims":[{"label":"shares_sold","value":"53,300"},{"label":"transaction_value_usd","value":"~2.14 million"},{"label":"weighted_avg_price_usd","value":"~40.21"},{"label":"market_close_price_usd_apr16_2026","value":"~41.40"},{"label":"direct_holdings_after","value":"1,137,599"},{"label":"indirect_holdings_after","value":"1,441,934"},{"label":"percent_of_total_holdings","value":"2.02%"},{"label":"percent_of_indirect_position","value":"3.56%"},{"label":"mean_prior_sell_only_event_shares","value":"20,782"}],"primary_claim":"Roger Jeffs disclosed an indirect sale of 53,300 Liquidia (LQDA) shares via Serendipity BioPharma LLC for approximately $2.14 million, executed under a Rule 10b5-1 plan.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Liquidia\u2019s CEO Roger Jeffs sold 53,300 shares indirectly via Serendipity BioPharma LLC for about $2.14 million in proceeds (weighted avg. price ~$40.21) during April 14\u201316, 2026. The filing indicates the sale was executed under a Rule 10b5-1 plan, suggesting a pre-scheduled liquidity event rather than a discretionary trade.","topics":["insider trading","SEC Form 4","Rule 10b5-1 plan","CEO share sale","ownership/holdings","biotechnology","Liquidia Yutrepia"]},"source":"Nasdaq Markets","source_domain":"fool.com","summary":"Key Points53,300 shares were sold indirectly for a transaction value of ~$2.14 million across April 14, 2026, to April 16, 2026, at a weighted average price of around $40.21 per share.","tickers":["LQDA"],"title":"Liquidia's (LQDA) CEO Sells 53,000 Shares for $2.1 Million","url":"https://www.fool.com/coverage/filings/2026/04/19/liquidia-s-lqda-ceo-sells-53-000-shares-for-usd2-1-million/"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 320575 in events